CEO Martin VanTrieste (Civica Rx)
March 3, 2022 01:22 PM EST
Pharma

Non­prof­it Civi­ca goes af­ter in­sulin prices in a big way, prep­ping for $30 vials by 2024

Zachary Brennan

Senior Editor

As mil­lions of in­sulin-de­pen­dent Amer­i­cans have seen their out-of-pock­et costs soar over the last few years, the mar­ket con­trolled by the three big in­sulin man­u­fac­tur­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times